An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn about the safety and the risks of using talimogene
laherparepvec in patients who already received treatment with talimogene laherparepvec in
study 005/05 (NCT00769704), and to see if extended treatment with talimogene laherparepvec
can destroy melanoma tumors.